Home › Stocks › APUS

APUS — APIMEDS PHARMACEUTICALS US I

Reported value held$1.12M
Funds holding (latest)20
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)9
Institutional value$360.97K · 72.30K sh
New / Add / Cut / Exit4 / 0 / 5 / 3 · Updated 2026-11-16
Top-5 / Top-10 concentration98.1% / 100.0%
Institutional holdings change Reducing -88.6% (-332.40K sh)
Institutional value change Down -36.7%

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 9 SEC-registered investment managers reported holding APUS (APIMEDS PHARMACEUTICALS US I) in their latest 13F filings, with a combined reported value of $360.97K across 72.30K shares. That is -88.6% by share count (-332.40K shares) versus the previous quarter, while reported value moved -36.7%. Ownership is concentrated: the five largest holders account for 98.1% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 4 opened new positions, 5 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of APIMEDS PHARMACEUTICALS US I (APUS) include Yorkville Advisors Global, LP, HRT FINANCIAL LP, Hemenway Trust Co LLC, ranked by reported 13F value among the 20 institutional holders on this page.

APUS is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 9 72.30K $360.97K -88.6%
Q2 2026 8 461.40K $415.25K -6.8%
Q1 2026 6 448.76K $802.95K +2.8%
Q4 2025 7 395.70K $648.95K +8.3%
Q3 2025 8 399.98K $711.81K +8.8%
Q2 2025 6 278.53K $490.22K —

Over the 6 quarters shown, institutional share counts decreased 74% in aggregate (Q2 2025 → Q3 2026); the largest single-quarter swing was Q3 2025 (+8.8%).

Top Institutional Holders (Q3 2026) — 9 funds

FundSharesValuePortfolio WeightChange
HRT FINANCIAL LP 29.51K $147.00K 0.00% New
Hemenway Trust Co LLC 27.40K $137.00K 0.01% Reduce
UBS Group AG 6.43K $32.15K 0.00% Reduce
VANGUARD CAPITAL MANAGEMENT LLC 5.16K $25.81K 0.00% Reduce
VANGUARD FIDUCIARY TRUST CO 2.40K $12.02K 0.00% Reduce
Tower Research Capital LLC (TRC) 1.38K $6.91K 0.00% Reduce
Ankerstar Wealth, LLC 15 $75 0.00% New
Citigroup Inc 1 $5 0.00% New
JPMorgan Chase & Co 1 $5 0.00% New

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 8 funds

FundSharesValuePortfolio WeightChange
Hemenway Trust Co LLC 274.00K $246.60K 0.02% Hold
VANGUARD CAPITAL MANAGEMENT LLC 63.65K $57.29K 0.00% Reduce
GEODE CAPITAL MANAGEMENT, LLC 35.11K $31.60K 0.00% New
Geode Capital Management 35.11K $31.60K 0.00% Reduce
VANGUARD FIDUCIARY TRUST CO 24.04K $21.64K 0.00% Hold
JANE STREET GROUP, LLC 15.99K $14.39K 0.00% New
UBS Group AG 11.82K $10.64K 0.00% Add
Tower Research Capital LLC (TRC) 1.66K $1.50K 0.00% New

Q1 2026 — 6 funds

FundSharesValuePortfolio WeightChange
Hemenway Trust Co LLC 274.00K $490.30K 0.04% Hold
VANGUARD CAPITAL MANAGEMENT LLC 95.93K $171.62K 0.00% New
Geode Capital Management 40.05K $71.67K 0.00% Add
VANGUARD FIDUCIARY TRUST CO 24.04K $43.01K 0.00% New
TWO SIGMA SECURITIES, LLC 10.55K $18.88K 0.00% New
UBS Group AG 4.19K $7.49K 0.00% Add

Q4 2025 — 7 funds

FundSharesValuePortfolio WeightChange
Hemenway Trust Co LLC 274.00K $449.36K 0.04% Add
Vanguard Group 58.99K $96.75K 0.00% Hold
Geode Capital Management 34.89K $57.22K 0.00% Add
JANE STREET GROUP, LLC 27.19K $44.59K 0.00% New
UBS Group AG 582 $954 0.00% New
Bank of America Corp 40 $66 0.00% Add
Tower Research Capital LLC (TRC) 10 $16 0.00% New

Q3 2025 — 8 funds

FundSharesValuePortfolio WeightChange
Hemenway Trust Co LLC 250.00K $445.00K 0.04% New
Vanguard Group 58.99K $105.00K 0.00% New
Geode Capital Management 30.75K $54.74K 0.00% New
Renaissance Technologies 27.89K $49.65K 0.00% New
XTX Topco Ltd 18.73K $33.35K 0.00% New
HRT FINANCIAL LP 13.57K $24.00K 0.00% New
Bank of America Corp 29 $52 0.00% Hold
JPMorgan Chase & Co 8 $14 0.00% Add

Q2 2025 — 6 funds

FundSharesValuePortfolio WeightChange
Yorkville Advisors Global, LP 250.00K $440.00K 0.26% New
Citadel Advisors 13.36K $23.51K 0.00% New
Goldman Sachs Group 11.99K $21.10K 0.00% New
Tower Research Capital LLC (TRC) 3.15K $5.55K 0.00% New
Bank of America Corp 29 $52 0.00% New
JPMorgan Chase & Co 5 $9 0.00% New

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025
HRT FINANCIAL LP 29.51K — — — 13.57K —
Hemenway Trust Co LLC 27.40K 274.00K 274.00K 274.00K 250.00K —
UBS Group AG 6.43K 11.82K 4.19K 582 — —
VANGUARD CAPITAL MANAGEMENT LLC 5.16K 63.65K 95.93K — — —
VANGUARD FIDUCIARY TRUST CO 2.40K 24.04K 24.04K — — —
Tower Research Capital LLC (TRC) 1.38K 1.66K — 10 — 3.15K
Ankerstar Wealth, LLC 15 — — — — —
JPMorgan Chase & Co 1 — — — 8 5
Citigroup Inc 1 — — — — —
Yorkville Advisors Global, LP — — — — — 250.00K
Vanguard Group — — — 58.99K 58.99K —
Geode Capital Management — 35.11K 40.05K 34.89K 30.75K —
Renaissance Technologies — — — — 27.89K —
JANE STREET GROUP, LLC — 15.99K — 27.19K — —
XTX Topco Ltd — — — — 18.73K —
GEODE CAPITAL MANAGEMENT, LLC — 35.11K — — — —
Citadel Advisors — — — — — 13.36K
Goldman Sachs Group — — — — — 11.99K
TWO SIGMA SECURITIES, LLC — — 10.55K — — —
Bank of America Corp — — — 40 29 29

Download holders (CSV)

FAQ

Which funds hold APUS?

As of 2026-Q3, 9 institutional funds reported holding APUS (APIMEDS PHARMACEUTICALS US I) in SEC 13F filings, with a combined reported value of $360.97K.

How many shares of APUS do institutions own?

13F filers reported 72.30K shares of APUS, worth $360.97K in aggregate at the end of 2026-Q3.

Is institutional ownership of APUS rising or falling?

Share counts moved -88.6% versus the prior quarter — distribution.

Who are the top institutional holders of APUS?

The largest 13F holders are Yorkville Advisors Global, LP, HRT FINANCIAL LP, Hemenway Trust Co LLC, Vanguard Group, Renaissance Technologies; the top 25 are ranked at the top of this page.

Who are the major shareholders of APIMEDS PHARMACEUTICALS US I?

The major shareholders of APIMEDS PHARMACEUTICALS US I (APUS) by reported 13F value are Yorkville Advisors Global, LP, HRT FINANCIAL LP, Hemenway Trust Co LLC, Vanguard Group, Renaissance Technologies, among 20 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own APUS" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/APUS/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →